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Abstract In this case series study, we prospectively
examined whether it might be possible to check the effect
of spinal anesthesia (SA), based on the disappearance of
lower extremity reflexes and spasticity, in patients with
spinal cord injury (SCI), in whom the effect cannot be
confirmed by the pinprick test or by using the Bromage
scale. In 40 patients with chronic, clinically complete
cervical SCI who were scheduled to receive SA, pre-
anesthetic examination revealed that the Babinski sign,
patellar tendon reflex, and spasticity (assessed using the
Ashworth scale) were all positive in 31 patients, while two
of these three pre-anesthetic assessment parameters were
positive in eight patients. The effect of SA in these 39
patients (97.5 %) was confirmed by demonstrating the
absence of both the Babinski sign and patellar tendon reflex
and loss of spasticity after SA. Our results suggested that
the effect of SA can be confirmed by the disappearance of
the Babinski sign and patellar tendon reflex and loss of
spasticity in most patients with complete cervical SCI,
although determination of the level of the block is difficult.
In conclusion, loss of the Babinski sign, patellar tendon
reflex, and spasticity might be useful for checking the
effect of SA in cervical SCI patients.
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Introduction
Anesthesia for patients with chronic spinal cord injury
(SCI) is required for the prevention of autonomic dysref-
lexia and spasticity [1]. Spinal anesthesia (SA) is an
effective anesthetic method that can prevent autonomic
dysreflexia and spasticity by blocking afferent nerve
impulses [1, 2]. It has been pointed out, however, that it
may be impossible to determine the level of the block in
SCI patients [1].
We had experienced a few SCI patients in whom auto-
nomic dysreflexia developed intraoperatively following SA
with only needle aspiration of cerebrospinal fluid. There-
fore, we attempted to establish a method of clinically
confirming anesthetic effects based on changes in neuro-
logical findings before the start of surgery.
A previous case report described loss of lower extremity
spasticity in a patient with cervical SCI following SA,
although the level of the block could not be determined [3].
Although disappearance of spasticity and the patellar ten-
don reflex (PTR) is known to occur following SA in
patients with cervical SCI [1, 4, 5], it still remains unclear
whether all patients with cervical SCI show lower
extremity spasticity and positive PTR before anesthesia.
Therefore, to clarify this problem, we examined patients
with chronic cervical SCI who demonstrated spasticity
(determined using the Ashworth scale), and had a positive
PTR and the Babinski sign (BS) before anesthesia. We then
assessed the patients for spasticity and the presence of PTR
and BS post-anesthesia and on postoperative day 1, in order
to confirm the effects of and recovery from SA.
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Case series
The study population comprised patients with chronic,
clinically complete cervical SCI who received SA between
April 2010 and August 2011 at Kanagawa Rehabilitation
Hospital. The protocol of the study was approved by the
Ethics Committee of this hospital and written informed
consent was obtained from all patients. Patients with the
usual contraindications to SA (coagulopathy, local infec-
tion of the puncture site, patient refusal) were excluded
from this study.
Before anesthesia and at 10 and 15 min after SA,
patients were tested for the presence of PTR and BS, while
flexion/extension at the hip joints, knee joints, and ankle
joints was assessed using the Ashworth scale for spasticity
grading (Table 1) [6]. Patients were assessed as positive for
spasticity when any of these joints showed grade 1, 2, 3, or
4 spasticity on the Ashworth scale, and as negative when
all these joints demonstrated grade 0 spasticity. Muscle
spasms and the onset of clonus were also regarded as
positive findings for PTR/BS and spasticity when the
reflexes and spasticity were examined. The above testing/
grading was performed by the same anesthesiologist in all
patients.
In the patients who underwent urological surgery,
changes in rectus abdominis muscle tone were assessed by
palpation before and after SA. For SA, 0.5 % hyperbaric
bupivacaine in 7.3 % glucose was administered via the
L3–4 or L4–5 intervertebral space with the patient in the
lateral position. If the patient was assessed as being posi-
tive for either PTR, BS, or spasticity at 15 min after SA,
SA was re-administered and surgery was allowed to com-
mence only after disappearance of PTR/BS and spasticity
bilaterally. On postoperative day 1, patients were re-
examined for the presence of PTR/BS and spasticity, using
the Ashworth scale, to compare the results with the pre-
operative data.
In all 40 patients enrolled in the study, surgery could be
performed without the need for general anesthesia and
without spasticity, severe hypotension, autonomic dysref-
lexia (defined as indirect systolic blood pressure of
160 mmHg or more in response to surgical stress), or any
other serious complications. In all cases, the surgeons
commented that they were able to perform the intraoperative
procedures without problems. Patient characteristics,
hemodynamic data, and pre-anesthetic neurological findings
are shown in Table 2.
In terms of the pre-anesthetic data, 31 of the 40 patients
showed positive PTR, BS, and spasticity, using the Ash-
worth scale, while eight patients were positive for two of
these three parameters (Table 2). The effects of SA in these
39 patients were confirmed by demonstrating the disap-
pearance of PTR/BS and spasticity after SA. In the
remaining patient, who had a history of C6 SCI sustained
34 years previously and T11-12 vertebral fracture
Table 1 Ashworth scale
0: No increase in tone
1: Slight increase in tone giving a ‘‘catch’’ when the limb
is moved in flexion or extension
2: More marked increase in tone, but limb easily flexed
3: Considerable increase in tone–passive movement difficult
4: Limb rigid in flexion as well as extension
Table 2 Patient characteristics, hemodynamic data, and pre-anes-
thetic positive rates for Babinski sign, patellar tendon reflex, and
spasticity (using the Ashworth scale)
Age (years) 44 (16–69)
Weight (kg) 57 ± 14
(35–91)
Height (cm) 168 ± 8
(150–181)
Male/female 30/10






Urological surgery 23 (57.5 %)
Decubitus ulcer surgery 11 (27.5 %)
Lower extremity surgery 2 (5 %)
Hemorrhoid surgery 4 (10 %)
Dose of 0.5 % hyperbaric bupivacaine for spinal
anesthesia (mg)
10 (8–15)
Incidence of hypotension (SBP \80 mmHg) 4 (10 %)
Lowest SBP within 30 min after SA (mmHg) 96 ± 17
(56–142)
Lowest HR within 30 min after SA (beats/min) 69 ± 11
(46–92)
Ephedrine supplement 4 (10 %)
Dose of ephedrine (mg) 4 (4–20)
Pre-anesthetic positive neurological findings
Babinski sign 38 (95 %)
Patellar tendon reflex 35 (87.5 %)
Spasticity 36 (90 %)
All three parameters positive 31 (77.5 %)
Positive for any two of the three parameters 8 (20 %)
Positive for any one of the three parameters 0 (0 %)
All parameters negative 1 (2.5 %)
Data are presented as medians (ranges), means ± standard deviation
(ranges), or numbers (%)
Ephedrine in increments of 4 mg was given intravenously to treat
hypotension, defined as decrease in SBP \80 mmHg
SBP systolic blood pressure, HR heart rate, SA spinal anesthesia
J Anesth (2012) 26:914–917 915
123
dislocations sustained 4 years before the present operation,
the effect of SA could not be confirmed due to the absence
of PTR/BS and spasticity pre-anesthesia.
Grading of spasticity on the Ashworth scale was not
possible in five patients because of contracture of the ankle
joints, although these patients were found to be positive for
spasticity in the other joints. In another patient, the patellar
reflex and spasticity grading on the Ashworth scale at the
knee joint could not be assessed due to fracture of
the patella; however, PTR/BS and spasticity were positive
in the remaining joints and in the contralateral lower
extremity.
In two patients who showed unilateral positive PTR/BS
after SA, re-administration of SA, with the patient in the
lateral position with the positive side down, resulted in loss
of the PTR/BS bilaterally.
By the time of their discharge from the operating room
(30–180 min after anesthesia), PTR/BS and spasticity had
disappeared in all patients. Although 19 of the 41 patients
perceived the disappearance of anesthetic effects due to the
perception of spasticity and the onset of autonomic dys-
reflexia 4–8 h after SA, the other patients did not have such
a perception. However, the neurological findings on post-
operative day 1 were consistent with those observed prior
to anesthesia in all patients. The patients told us that their
lower limb sensations were the same as those before
anesthesia.
Discussion
In this study, the effect of SA was confirmed in 39 of 40
patients (97.5 %) by demonstrating the absence of the
assessment parameters of PTR, BS, and spasticity after SA.
Our results suggest that the effect of SA in most patients
with complete cervical SCI can be confirmed by the dis-
appearance of PTR, BS, and spasticity.
Spasticity is a sign of upper motor neuron syndrome [7],
which results from corticospinal tract damage. The syn-
drome is associated with signs such as spasms, spastic
paralysis, hyperactive tendon reflexes, and BS, and is
thought to result from adaptive changes in transmission in
the spinal networks distal to lesions of descending motor
pathways [8, 9]. The BS is thought to be part of the general
withdrawal reflex synergy released by a lesion of the
supraspinal pathways that project onto the interneuronal
zone of the lumbosacral cord (L5, S1) [10]. The PTR is a
spinal reflex, with its center located in the lumbar spinal
cord (L2–4), and the reflex is often enhanced by damage to
the upper motor neurons.
Most patients in the present study demonstrated spastic-
ity, determined using the Ashworth scale, and positive PTR/
BS before SA, because, as it was inferred, most patients with
chronic cervical SCI, such as our patients, present with signs
of upper motor neuron syndrome.
However, some patients in the present series exhibited
negative PTR and BS even before SA. Although the cause
for these findings remains unclear, they can probably be
explained by flaccid paralysis caused by peripheral neu-
ropathy [11].
There were eight patients who were negative for any one
of the three assessment parameters employed in this study,
i.e., spasticity using the Ashworth scale, PTR, and BS.
Testing all of the three assessment parameters might,
therefore, increase the probability of confirmation of the
effect of SA.
One patient in this study was found to be negative for all
three of the assessment parameters before SA; he had
developed loss of spasticity after suffering T11–12 verte-
bral fracture dislocations 4 years earlier. It is likely that
this patient had developed flaccid paralysis due to a lower
spinal cord injury associated with the T11–12 fracture
dislocations.
Two patients in this study showed unilateral positive
PTR and BS after the first SA, with bilaterally negative
findings after SA was performed again. It is thus thought
that the effect of SA might be checked by ascertaining
whether positive PTR/BS becomes negative following SA.
The return of PTR, BS, and spasticity on the Ashworth
scale to pre-anesthetic levels on postoperative day 1 in all
the patients studied indicated the disappearance of the
effects of SA by the following day.
Nevertheless, determination of the level of the block in
SCI patients is difficult. It is only possible to indirectly
estimate the effectiveness of anesthesia from the absence of
BS (S1–L5), PTR (L2–4), or hip joint relaxation on the
Ashworth scale (L1). The level of the block required for
surgeries for hemorrhoids, decubitus ulcers of the sacral or
ischial region, and for the lower extremities is L1 or lower.
These surgeries can be smoothly performed without any
intraoperative autonomic dysreflexia or spasticity after
confirming that PTR/BS and spasticity have become neg-
ative. Using these assessment parameters alone, however, it
is difficult to confirm the adequacy of the level of SA in
patients for urological surgeries, such as cystostomy and
transurethral operations, in which block levels of T10 or
higher are required [12]. Interestingly, among the 23
patients in this series who underwent urological surgeries,
there were two patients in whom relaxation of rectus ab-
dominis muscle tone could be confirmed by palpation.
Hence, it is possible that changes in rectus abdominis
muscle tone might be useful for checking the effect of SA
in some SCI patients.
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